Is there some (Bayesian or other) reason that the endpoint was a 43% reduction?
Why wouldn't a smaller reduction have been sufficient?
Noting that we haven't been told the actual reduction.
Ann: Mesoblast Update on COVID-19 ARDS Trial, page-128
-
- There are more pages in this discussion • 948 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.030(2.52%) |
Mkt cap ! $1.370B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $4.167M | 3.530M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 19199 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 8187 | 5 |
View Market Depth
| Last trade - 13.24pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |